Analysis of worldwide surgical outcomes in COVID-19-infected patients: a gynecological oncology perspective
File(s)
Published version
Author(s)
Phelps, David L
Saso, Srdjan
Ghaem-Maghami, Sadaf
Type
Journal Article
Abstract
Coronavirus Disease 2019 (COVID-19) guidance limits all but the most urgent surgery in the United Kingdom. We review the literature and our experience in gynecology to assess perioperative outcomes. PubMed was searched with (surg*[Title])AND(COVID[Title]), (surg*[Title])AND(2019-nCoV[Title]), and (surg*[Title])AND(SARS-CoV-2[Title]), and 67 COVID-19-positive surgical patients across ten hospitals in four countries are included. Median mortality was 33%. Cardiac and pulmonary co-morbidities associated with higher risk of COVID-19-positive postoperative death. Mortality was high in neurosurgery (80%) and the lowest in gynecological oncology surgery (none). This analysis provides an evidence base on which to consider surgical risk assessment for different specialties. Risk of perioperative death needs to be assessed in the context of patients’ co-morbidities and surgical specialty. An individualized approach toward surgical decision making is imperative.
Date Issued
2020-08-21
Date Acceptance
2020-08-07
Citation
Future Science OA, 2020, 6 (10), pp.1-8
ISSN
2056-5623
Publisher
Future Science
Start Page
1
End Page
8
Journal / Book Title
Future Science OA
Volume
6
Issue
10
Copyright Statement
© 2020 D Phelps. This work is licensed under the Creative Commons Attribution 4.0 License. To view a copy of this license, visit
http://creativecommons.org/licenses/by/4.0/
http://creativecommons.org/licenses/by/4.0/
License URL
Identifier
https://www.future-science.com/doi/10.2144/fsoa-2020-0099
Subjects
Science & Technology
Life Sciences & Biomedicine
Medicine, Research & Experimental
Research & Experimental Medicine
cancer
COVID
COVID-19
gynecological oncology surgery
review
SARS-CoV-2
Publication Status
Published
Date Publish Online
2020-08-21